| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 8736673 | The Brazilian Journal of Infectious Diseases | 2018 | 7 Pages | 
Abstract
												The results point to the effectiveness of second-generation direct-acting antivirals in hepatitis C virus Brazilian patients, especially those with genotype 1. Furthermore, that patients with genotype 3 need more attention and adjustments in available treatment options.
											Related Topics
												
													Life Sciences
													Immunology and Microbiology
													Immunology and Microbiology (General)
												
											Authors
												Vinicius Lins Ferreira, Helena Hiemisch Lobo Borba, Astrid Wiens, Maria Lucia Alves Pedroso, Vanessa Ferreira de Camargo Radunz, Cláudia Alexandra Pontes Ivantes, Aline Satie Oba Kuniyoshi, Roberto Pontarolo, 
											